SCIENTISTS seeking to make chemotherapies which are less harmful to cancer patients have reported "highly promising" results from a synthetic molecule called TPP. Laboratory tests found a series of ...
TPP Global Development and Sweden’s Sprint Biosciences inked a collaboration focused on the development of small molecule choline kinase inhibitors for the treatment of cancer. U.K-based TPP is a drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback